Lisa Cosgrove, PhD is a Clinical Psychologist and Professor at the University of Massachusetts, Boston where she teaches courses on psychiatric diagnosis and psychopharmacology. A former Research Fellow at the Edmond J. Safra Center for Ethics, Harvard University (2010-2015), her research addresses the ethical and medical-legal issues that arise in organized psychiatry because of academic-industry relationships. Lisa has published articles, book chapters, and has co-edited casebooks on these topics and her research has received significant attention by the national and international media. She is co-author, with Robert Whitaker, of Psychiatry under the Influence: Institutional Corruption, Social Injury, and Prescriptions for Reform. She received a 2015 Distinguished Publication Award, given by the Association for Women in Psychology, for her paper (with Emily Wheeler), “Industry’s colonization of psychiatry.” Lisa was the PI for an RO3 NIH grant, “A cross-sectional study of clinical practice guidelines for depression: Is guideline quality associated with independence from industry?” She is co-chair of the task force on Depression Outcome Measures, Agency for Healthcare Research and Quality.

Recent Selected publications

Cosgrove L, Shaughnessy AF, Peters SM, Lexchin JR, Bursztajn H, Bero L. Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder. Psychother Psychosom. 2017; 86(3): 168-170.

Simons, P., Cosgrove, L., Shaughnessy, A. and Bursztajn, H.. Antipsychotic Augmentation for Major Depressive Disorder: A Review of Clinical Practice Guidelines. Int J Law Psychiatry. 2017

Shaughnessy, A. S., Cosgrove, L. Lexchin, J. The need to regulate clinical practice guidelines. J Am Board Fam Med. 2016. 29:644–8. doi:10.3122/jabfm.2016.06.160115

Cosgrove, L., Mintzes, B., Vannoy, S., Shaughnessy A. F., Under the influence: Industry, publishing, and drug regulation. Account Res, 2016. 24, 1-23.

Thombs BD, Saadat N, Riehm KE, Karter JM, Vaswani A, Andrews BK, Simons P, Cosgrove L. Consistency and sources of divergence in recommendations on screening with questionnaires for presently experienced health problems or symptoms: a comparison of recommendations from the Canadian Task Force on Preventive Health Care, UK National Screening Committee, and US Preventive Services Task Force. BMC Med. 2017 Aug 9;15(1):150.

Shaughnessy AF, Vaswani A, Andrews BK, Erlich DR, D’Amico F, Lexchin J, Cosgrove L. Developing a Clinician Friendly Tool to Identify Useful Clinical Practice Guidelines: G-TRUST. Ann Fam Med. 2017 Sep;15(5):413-418.

Cosgrove, L. et al. From Caveat Emptor to Caveat Venditor: Time to stop the influence of money on practice guideline development. J Eval Clin Pract. 2015. 20, 809-812.

Cosgrove, L., Krimsky, S. Wheeler, E., Katz, J. Greenspan, S. DiPentima, N. Tripartite Conflicts of Interest and High Stakes Patent Extensions in the DSM-5. Psychother and Psychosom, 2014. 83, 106-113.

Cosgrove, L., & Wheeler, E. E. Drug firms, the codification of diagnostic categories, and bias in clinical guidelines. J Law Med Ethics, 2013. 14, 644-653.

Cosgrove, L., & Krimsky, S. (2012). A comparison of DSM IV and DSM-5 panel members’ financial associations with industry: A pernicious problem persists. PLoS Med, 9(3), e1001190.

Cosgrove L, Bursztajn HJ, Erlich DR, Wheeler EE, Shaughnessy AF. Conflicts of interest and the quality of recommendations in clinical guidelines. J Eval Clin Pract. 2013 Aug;19(4):674-81.

Cosgrove, L., Ling, S., Creasey, D., Anaya-McKivergan, MS; Myers, J. Huybrechts, MS. (2011). Antidepressants and breast and ovarian cancer risk: A systematic review of the epidemiological and pre-clinical literature and researchers’ financial associations with industry. PLoS ONE, 6, 1-8.